Results from the EURO-SKI cessation trial of TKIs in CML

Sequencing multiple myeloma reveals a complex landscape of genetic lesions

Super-enhancer analysis reveals subtypes in AML and MDS

Better screening programmes needed for haematological malignancies such as leukaemia

Karyotyping a CLL subset with ibrutinib susceptibility

Chemo-genomic interrogation reveals JAK sensitive subgroup in AML

Decoding the risk of thromboembolic events in lymphoma patients

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Sequencing analysis with circulating DNA

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers

First in-human trials of rovalpituzumab for SCLC